Incidence of Refeeding Syndrome in Consecutively Admitted Patients
Refeeding Syndrome - Incidence and Risk Factors: An Observational Study on Patients With G-I Disease and Head-neck Cancer
1 other identifier
observational
51
0 countries
N/A
Brief Summary
The incidence and main risk-factors analyzed in consecutive in-patients in the departments og gastroenterology and ear-nose and throat diseases (cancer in radiation therapy)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 21, 2023
CompletedFirst Posted
Study publicly available on registry
August 1, 2023
CompletedAugust 14, 2023
August 1, 2023
6 months
July 21, 2023
August 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Refeeding syndrome
No. patients with decrease in plasma phosphate + clinical symptoms
1 week after start of nutrition
Secondary Outcomes (1)
Refeeding phenomenon
1 week after start of nutrition
Study Arms (2)
gastroenterological
Consecutive admissions - n= 43 - 34 operated (79%) - 10 patients acutely admitted Diseases in Esophagus (8), gastric cavity (8), pancreas (7), colon/rectum (8), bile (4), small intestine (3), IBD (5) No interventions in the treatments, just observation
head and neck cancer
Consecutive admissions - n=8 - 7 radiation therapy - 1 operated Locations: 2 Larynx, 1 oro-pharynx, 4 tonsillar, 1 tung No interventions in the treatments, just observation
Interventions
Eligibility Criteria
No other than willingness to participate and consecutively admitted, as well as planned sufficient nutrition
You may qualify if:
- planned tube- or parenteral nutrition (complete or supplementary)
- \> 18 years
- written consent
You may not qualify if:
- Renal insufficiency (p-creatinine \>200 micromol/l)
- Lack of ability to communicate (registration of nutritional intake etc)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jens Rikardt Andersenlead
- St. Olavs Hospitalcollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
jens R Andersen, MD, MPA
University of Copenhagen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assoc Prof
Study Record Dates
First Submitted
July 21, 2023
First Posted
August 1, 2023
Study Start
December 1, 2013
Primary Completion
May 31, 2014
Study Completion
July 1, 2023
Last Updated
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share